Oakview Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Oakview Capital Management's PFE Position: Q2 2021 in Review
Oakview Capital Management sold out of Pfizer (PFE) in Q2 2021, closing a stake of 273,706 shares — an estimated $9.92M sold.
Oakview Capital Management first reported a position in PFE in Q4 2016 and held it in 17 quarters. The position peaked at $28.7M in Q1 2018. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.
- Oakview Capital Management reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
- Oakview Capital Management sold 273,706 Pfizer shares in Q2 2021, an estimated $9.92M.
- Oakview Capital Management first reported a position in Pfizer in Q4 2016 and held it in 17 quarters.
- Oakview Capital Management's Pfizer position peaked at $28.7M in Q1 2018.
- 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.
Based on Oakview Capital Management's 13F filing for Q2 2021, filed 6 Aug 2021.